Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 22288298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide and hypertension.

  2012cited by this paper
• Acute Intravenous l-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients With Angina Pectoris and Normal Coronary Arteriograms: Correlation With Asymmetric Dimethylarginine Levels

  2003cited by this paper
• Oral L-arginine improves endothelial function in healthy individuals older than 70 years

  2003cited by this paper
• Endothelial function: a barometer for cardiovascular risk?

  2002cited by this paper
• Oral Arginine Reduces Systemic Blood Pressure in Type 2 Diabetes: Its Potential Role in Nitric Oxide Generation

  2002cited by this paper
• Clinical presentation and diagnosis of coronary artery disease: stable angina.

  2001cited by this paper
• L-arginine infusion lowers blood pressure in children.

  2001cited by this paper
• Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension

  2001cited by this paper
• Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients

  2001cited by this paper
• Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension.

  2001cited by this paper
• Effects of oral l-arginine on plasma nitrate and blood pressure in cortisol-treated humans

  2001cited by this paper
• Blood pressure and metabolic changes during dietary L-arginine supplementation in humans.

  2000cited by this paper
• Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris.

  1999cited by this paper
• L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.

  1998cited by this paper
• Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans.

  1998cited by this paper
• L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.

  1997cited by this paper
• Basal nitric oxide synthesis in essential hypertension.

  1997cited by this paper
• Nitric oxide and hypertension.

  1996cited by this paper
• The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans.

  1996cited by this paper
• Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.

  1995cited by this paper
• Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension.

  1995cited by this paper
• Metabolic effects of arginine in a healthy elderly population.

  1995cited by this paper
• Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.

  1995cited by this paper
• Orall-arginine supplementation has no effect on cardiovascular responses to lower body negative pressure in man

  1994cited by this paper
• Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level.

  1994cited by this paper
• Effects of L-arginine on forearm vessels and responses to acetylcholine.

  1992cited by this paper
• Arginine needs, physiological state and usual diets. A reevaluation.

  1986cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• [Natural treatment of hypertension].

  1956cited by this paper

• Safety assessment of L-Arg oral intake in healthy subjects: a systematic review of randomized control trials

  2023cites this paper
• The effects of a comparatively higher dose of 1000 mg/kg/d of oral L- or D-arginine on the L-arginine metabolic pathways in male Sprague-Dawley rats

  2023cites this paper
• Effects of acute arginine supplementation on neuroendocrine, metabolic, cardiovascular, and mood outcomes in younger men: A double-blind, placebo-controlled trial

  2022cites this paper
• The Effect of L-arginine Supplementation On Blood Pressure in Adults: A Systematic Review and Dose-response Meta-analysis of Randomized Clinical Trials.

  2021cites this paper
• Effects of L-arginine Supplementation and Aerobic Training on Hemodynamic Indices of Obese Men

  2019cites this paper
• The effects of oral arginine on its metabolic pathways in Sprague–Dawley rats

  2019cites this paper
• The Effect of Oral L-arginine Supplementation on Blood Pressure in Patients with Metabolic Syndrome: A Randomized Clinical Trial

  2018cites this paper
• Taste and Hypertension in Humans: Targeting Cardiovascular Disease.

  2016cites this paper
• The Effect of L-arginine Supplementation on Blood Pressure in Patients with Type 2 Diabetes: A Double-Blind Randomized Clinical Trial

  2016cites this paper
• The Effect of Supplementation of L - Arginine on the Lipid Profile, Fasting Blood Sugar and Blood Pressure in Healthy Subjects with the preventive Approach of Cardiovascular Diseases

  2015cites this paper
• Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.

  2012cites this paper